DOCS vs INCY · P/E 21, rev $570.4M vs P/E 14, rev $4.24B
Doximity Inc (DOCS) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported INCY revenue for 2024-12-31 was $4.24B. Net income was $32.6M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the DOCS and INCY stock pages for the full models.
Not investment advice.